Stephen Burke

Structural basis of West Nile virus neutralization by a therapeutic antibody

Grant E. Nybakken, Theodore Oliphant, Syd Johnson et al. · Nature · 2005 · 354 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells <i>In vitro</i> and Controls Tumor Expansion <i>In vivo</i> via Low-Affinity Activating Fcγ Receptors

Jeffrey B. Stavenhagen, Sergey Gorlatov, Nadine Tuaillon et al. · Cancer Research · 2007 · 278 citations · Full text

Pharmacy, Immunology, Oncology +17

Effector Cell Recruitment with Novel Fv-based Dual-affinity Re-targeting Protein Leads to Potent Tumor Cytolysis and in Vivo B-cell Depletion

Syd Johnson, Stephen Burke, Ling Huang et al. · Journal of Molecular Biology · 2010 · 192 citations

Medicine, Immunology, Oncology +15

Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/− cells

Erik J. Uhlmann, Anthony J. Apicelli, Rebecca L. Baldwin et al. · Oncogene · 2002 · 83 citations

Life Sciences, Genetics, Molecular Genetics +12

Therapeutic control of B cell activation via recruitment of Fcγ receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold

Maria-Concetta Verı́, Stephen Burke, Ling Huang et al. · Arthritis & Rheumatism · 2010 · 73 citations

Life Sciences, Immunology, Molecular Biology +17